Protalix BioTherapeutics (PBDA.STU) Q2 2026 Earnings

13MayConfirmed
Q2 2026
-0.01
0.06
0.12
0.19

Details

Expected EPS
-0.008534
Actual EPS
0.187748
Surprise EPS
0.2
Surprise Percent
+2,300%

Description

Protalix BioTherapeutics (PBDA.STU) has reported earnings of 0.187748 per share for Q2 2026.

0 Comments

Share your thoughts